Application Of Autologous Blood Products During Modified Radical Mastectomy

Status unconfirmed · Phase 3

Conditions studied: Mastectomy

In brief

The purpose of this study is to determine if the application of autologous (your own blood) blood products during mastectomy improves wound healing and decreases complications following surgery compared to mastectomy without the use of autologous blood products.

Key facts

Study ID

NCT00802477

Run by

Marshall University

People needed

100

Starts

2008-12-01

Expected to finish

2012-03-01

Last updated by the study team

2011-08-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient undergoing a modified radical mastectomy, simple mastectomy or axillary lymph node dissection.
• Patient signature of informed consent form

You may not qualify if…

• Pregnancy
• < 18 years of age
• History of anemia (hemoglobin < 11.0)
• History of any blood disorder, deep vein thrombosis, pulmonary emboli or clotting disorders.
• Un-cooperative patient or patient with neurological disorders who are incapable of following directions or who are predictably unwilling to return for follow-up examinations
• Allergy to bovine products
• History of MRSA in last 12 months
• Communicable disease or diseases that may limit follow- up (e.g. immunocompromised conditions, hepatitis, active tuberculosis)

Where it is running

• University Oncology Services at Edwards Comprehensive Cancer Center — Huntington, West Virginia, United States (enrolling)
• University Oncology Services at Edwards Comprehensive Cancer Center — Huntington, West Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.